Matthews International Capital Management LLC Burning Rock Biotech LTD Transaction History

Matthews International Capital Management LLC

$589 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$1.75 - $10.44 $2.66 Million - $15.9 Million	-1,521,308 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$6.7 - $10.23 $305,520 - $466,488	-45,600 Reduced 2.91%	1,521,308 $14.1 Million
Q4 2021 Feb 02, 2022	SELL	$9.43 - $17.14 $3.99 Million - $7.26 Million	-423,500 Reduced 21.28%	1,566,908 $14.9 Million
Q2 2021 Aug 10, 2021	BUY	$26.14 - $37.45 $7.96 Million - $11.4 Million	304,500 Added 18.06%	1,990,408 $58.6 Million
Q4 2020 Feb 09, 2021	BUY	$22.55 - $30.87 $6.85 Million - $9.37 Million	303,639 Added 21.97%	1,685,908 $38.9 Million
Q3 2020 Nov 05, 2020	SELL	$19.07 - $29.61 $8.21 Million - $12.7 Million	-430,300 Reduced 23.74%	1,382,269 $34.7 Million
Q2 2020 Jul 29, 2020	BUY	$23.21 - $31.43 $42.1 Million - $57 Million	1,812,569 New	1,812,569 $49 Million

Others Institutions Holding BNR

# of Institutions

Shares Held

21.2K

Call Options Held

Put Options Held

Sc China Holding LTD N/A, K3

21.2K
Shares

$118,787
0.0% of portfolio

View Full List

About Burning Rock Biotech Ltd

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $589M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

More about BNR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account